Mkoh

    • MkohMkoh
      ·02-06

      Navigating the Private Equity Meltdown: Software Exposure – Drag or Discounted Opportunity?

      The private equity sector has been rocked by a sharp sell-off in recent days, with shares of major players tumbling amid growing investor anxiety over their heavy bets on software companies. As artificial intelligence continues to reshape industries, questions swirl around whether these firms' portfolios – laden with software investments acquired at peak valuations – represent a toxic liability or a timely bargain for long-term investors. The meltdown, which wiped out billions in market value, underscores the vulnerability of leveraged software assets in an era of rapid technological disruption. But it also raises the prospect of undervalued stocks for those willing to bet on adaptation and recovery. At the heart of the turmoil is the private equity industry's deep entanglement with softwa
      1162
      Report
      Navigating the Private Equity Meltdown: Software Exposure – Drag or Discounted Opportunity?
    • MkohMkoh
      ·02-05

      Have the Magnificent Seven Destroyed Index Investing?

      In the world of investing, index funds have long been hailed as the epitome of simplicity and safety. By tracking broad market indices like the S&P 500, they offer diversification across hundreds of companies, theoretically spreading risk and capturing the overall market's growth. However, the rise of the "Magnificent Seven" (Mag 7)—Apple, Amazon, Alphabet, Meta, Microsoft, Nvidia, and Tesla—has sparked intense debate. These tech behemoths have dominated market performance in recent years, but their outsized influence raises a critical question: Have they undermined the very foundation of index investing by turning diversified funds into concentrated bets on a handful of stocks? The Rise of the Mag 7 and Market ConcentrationThe Mag 7's ascent began in earnest during the AI boom of the
      1651
      Report
      Have the Magnificent Seven Destroyed Index Investing?
    • MkohMkoh
      ·02-04
      Investment Analysis: Is Anthropic Breaking the Software Business? Let's get real about this: Anthropic is legitimately shaking the foundations of the traditional software business, and the market's violent reaction over the past few days proves it. No sugarcoating—Claude Cowork's plugins (dropped on January 30) just triggered one of the ugliest sector sell-offs we've seen in years, wiping out an estimated $285 billion in combined market value from software, legal tech, professional services, and related names in a single brutal session, with the pain spilling into a second day.The numbers don't lie: Thomson Reuters plunged 15-18% (its worst single-day drop ever), RELX down 14%, Wolters Kluwer around 13%, LegalZoom getting hammered nearly 20%. Even broader plays like Sage, Pearson, Experian
      635Comment
      Report
    • MkohMkoh
      ·02-02
      102Comment
      Report
    • MkohMkoh
      ·01-29
      $Microsoft(MSFT)$ picking up when sentiments are bad. This is for long term holding 
      211Comment
      Report
    • MkohMkoh
      ·01-29
      106Comment
      Report
    • MkohMkoh
      ·01-28
      TSLA-C MSFT-B APPL-B META-C (TSLA) – Q4 2025 Consensus: Revenue ~$24.75–$24.8B (down ~3–4% YoY); EPS ~$0.33–$0.45 (down 30–50% YoY). Deliveries down ~16% YoY amid competition and demand weakness; Energy storage a bright spot. Watch: FSD/Robotaxi/Optimus updates and tough 2026 outlook. (MSFT) – Fiscal Q2 2026 Consensus: Revenue ~$80.2–$80.3B (up ~15% YoY); EPS ~$3.88–$3.92 (up ~20% YoY). Azure growth in mid-to-high 30s% (constant currency) from AI/Copilot demand. Key: Capex rise and ROI amid heavy AI investments. (AAPL) – Fiscal Q1 2026 (Dec quarter) Consensus: Revenue ~$138–$139B (up ~10–12% YoY); EPS ~$2.65–$2.67 (up ~10–11% YoY). Strong iPhone holiday sales and Services drive rebound. Focus: China trends, AI/Siri progress, and forward catalysts. META – Q4 2025 Consensus: Reven
      520Comment
      Report
    • MkohMkoh
      ·01-24
      $NVDA 20260123 160.0 PUT$ full premium at expiry 
      227Comment
      Report
    • MkohMkoh
      ·01-23
      Whether you should open more 0DTE positions depends on your risk appieitey. Here’s the breakdown to help you decide. 1. The 0DTE Opportunity The primary reason to trade 0DTE on Mondays and Wednesdays is to capture hyper-accelerated time decay (Theta).  Income Frequency: Instead of waiting a month for an option to expire, you can collect premiums 252 days a year. Limited Overnight Risk: Since you enter and exit on the same day, you aren't vulnerable to "gap downs" or "gap ups" caused by news that breaks while the market is closed. Low Capital Requirement: 0DTE options are much cheaper than longer-dated ones, providing massive leverage.  The Middle Ground: Many traders in 2026 are using 0DTE-based ETFs (like $QDTE or $XDTE). These funds do the 0DTE selling for you, providing
      9362
      Report
    • MkohMkoh
      ·01-23

      Abott ABT US earnings recap and the sharp market correction in share price

      Abbott Laboratories (ABT) reported its Q4 2025 earnings (for the quarter ended December 31, 2025) on January 22, 2026, with the following key results:Revenue: $11.46 billion, up 4.4% year-over-year on a reported basis and +3.0% organically. This missed Wall Street consensus estimates of around $11.8 billion (a shortfall of roughly $340 million). Adjusted EPS: $1.50, in line with (or slightly beating) analyst expectations, up about 12% from the prior-year quarter. Full-year 2025: Revenue ~$44.3 billion (+5.5–5.7% organic), adjusted EPS $5.15 (+10%). The market reaction was sharply negative, with ABT stock dropping significantly in trading on January 22, 2026 — declines reported in the range of ~5–10% (pre-market to intraday, with some sources noting peaks around 10–11% at points, closing lo
      1.15K2
      Report
      Abott ABT US earnings recap and the sharp market correction in share price
       
       
       
       

      Most Discussed